People · Operator
Named in public records as an officer, director or promoter · active 2012–2012 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Rib X Pharmaceuticals Inc | — | Pharmaceuticals | Series B | $29.7M | $635.4M | 2012 |
Cecilia S. Gonzalo at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Cecilia S. Gonzalo on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jonathan Leff | 1 | 11 |
| Harry H Penner, Jr. | 1 | 6 |
| Mark Leuchtenberger | 1 | 3 |
| Jonathan S. Leff | 1 | 3 |
| Cecilia Gonzalo | 1 | 2 |
| George M. Milne, Jr. | 1 | 2 |
| Robert Conerly | 1 | 2 |
| Raymond H. Whitaker | 1 | 1 |
| C. Boyd H. Clarke | 1 | 1 |
| George H. Milne | 1 | 1 |
| Jonathan H. Fleming | 1 | 1 |
| Peter H. Greenleaf | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.